XML 56 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Option and Stock Award Plans (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 03, 2012
Feb. 26, 2011
Feb. 27, 2010
Stock options and stock award Plans      
Stock-based compensation costs $ 15,861 $ 17,336 $ 23,794
Shares of common stock authorized under stock-based compensation plans 89,446    
Maximum
     
Additional General Disclosures      
Maximum expiration term (in years) P10Y    
Stock options
     
Fair value assumptions      
Expected stock price volatility (as a percent) 79.00% 79.00% 76.00%
Risk-free interest rate (as a percent) 1.45% 1.92% 2.50%
Expected option life (in years) 5.5 5.5 5.5
Plan Awards, Additional Disclosures      
Weighted average Fair value of options granted (in dollars per share) $ 0.82 $ 0.71 $ 0.83
Shares      
Outstanding at the beginning of the period (in shares) 74,298 76,114 70,162
Granted (in shares) 23,200 17,443 18,367
Exercised (in shares) (896) (244) (75)
Cancelled (in shares) (22,804) (19,015) (12,340)
Outstanding at the end of the period (in shares) 73,798 74,298 76,114
Vested or expected to vest at the end of the period (in shares) 65,622    
Exercisable at the end of the period (in shares) 29,544    
Weighted Average Exercise Price Per Share      
Outstanding at the beginning of the period (in dollars per share) $ 2.47 $ 3.08 $ 3.80
Granted (in dollars per share) $ 1.19 $ 1.07 $ 1.26
Exercised (in dollars per share) $ 1.02 $ 0.92 $ 0.89
Cancelled (in dollars per share) $ 4.31 $ 3.66 $ 4.48
Outstanding at the end of the period (in dollars per share) $ 1.52 $ 2.47 $ 3.08
Vested or expected to vest at the end of the period (in dollars per share) $ 1.57    
Exercisable at the end of the period (in dollars per share) $ 2.08    
Weighted Average Remaining Contractual Term      
Outstanding at the end of the period (in years) 7.16    
Vested or expected to vest at the end of the period (in years) 7.04    
Exercisable at the end of the period (in years) 5.95    
Aggregate Intrinsic Value      
Outstanding at the end of the period 35,568    
Vested or expected to vest at the end of the period 31,206    
Exercisable at the end of the period 12,595    
Additional General Disclosures      
Total unrecognized pre-tax compensation costs, net of forfeitures 20,136    
Weighted-average period over which remaining share-based cost is expected to be recognized (in years) 2.47    
Cash received from stock option exercises 914 226 66
Total intrinsic value of options exercised 255 81 44
Stock options | Non-employee director
     
Additional General Disclosures      
Vesting period (in years) 3 years    
Stock options | Employee
     
Additional General Disclosures      
Vesting period (in years) 4 years    
New stock options
     
Shares      
Granted (in shares) 5,300    
Cancelled (in shares) (14,000)    
Weighted Average Exercise Price Per Share      
Granted (in dollars per share) $ 1.03    
Additional General Disclosures      
Vesting period (in years) 2 years    
Maximum expiration term (in years) P5Y    
Options cancelled, exercise price in excess of specified price (in dollars per share) $ 1.77    
Restricted stock
     
Additional General Disclosures      
Total unrecognized pre-tax compensation costs, net of forfeitures 9,487    
Weighted-average period over which remaining share-based cost is expected to be recognized (in years) 2.49    
Shares      
Outstanding at the beginning of the period (in shares) 7,078 5,944 6,699
Granted (in shares) 8,525 4,574 3,289
Vested (in shares) (3,366) (3,055) (3,387)
Cancelled (in shares) (731) (385) (657)
Outstanding at the end of the period (in shares) 11,506 7,078 5,944
Weighted Average Grant Date Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 1.12 $ 2.26 $ 3.87
Granted (in dollars per share) $ 1.23 $ 1.07 $ 1.28
Vested (in dollars per share) $ 1.11 $ 3.21 $ 4.35
Cancelled (in dollars per share) $ 1.16 $ 1.65 $ 3.03
Outstanding at the end of the period (in dollars per share) $ 1.20 $ 1.12 $ 2.26
Additional Disclosures      
Total fair value of awards vested during the period $ 3,724 $ 9,819 $ 14,726
Restricted stock | Maximum
     
Additional General Disclosures      
Vesting period (in years) 3 years    
Restricted stock | Non-employee director
     
Additional Disclosures      
Portion of non-employee director award vesting in year one (as a percent) 80.00%    
Portion of non-employee director award vesting in year two (as a percent) 10.00%    
Portion of non-employee director award vesting in year three (as a percent) 10.00%    
Stock options and restricted stock
     
Additional Disclosures      
Portion of employee stock options and awards vesting in year three (as a percent) 50.00%    
Portion of employee stock options and awards vesting in year four (as a percent) 50.00%    
1990 Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 22,000    
1999 Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 10,000    
2000 Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 22,000    
2001 Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 20,000    
2004 Omnibus Equity Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 20,000    
2006 Omnibus Equity Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 50,000    
2010 Omnibus Equity Plan
     
Stock options and stock award Plans      
Shares of common stock authorized under stock-based compensation plans 35,000